Raymond James Downgrades Monopar Therapeutics (MNPR) to Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Raymond James Downgrades Monopar Therapeutics (MNPR) to Outperform
(NASDAQ: MNPR) Delayed: 118.55 +2.27 (1.95%)
Previous Close $116.28    52 Week High $ 
Open $117.44    52 Week Low $ 
Day High $121.02    P/E N/A 
Day Low $115.07    EPS $ 
Volume 208,568